Vaccines News StoriesExcerpts of Key Vaccines News Stories in Major Media
Note: This comprehensive list of vaccines news stories is usually updated once a week. Explore our full index to revealing excerpts of key major media news stories on several dozen engaging topics. And don't miss amazing excerpts from 20 of the most revealing news articles ever published.
More than half the scientists on the swine flu taskforce advising the [UK] Government have ties to drug companies. Eleven of the 20 members of the Scientific Advisory Group for Emergencies (SAGE) have done work for the pharmaceutical industry or are linked to it through their universities. Many have declared interests in GlaxoSmithKline, the vaccine maker expected to be the biggest beneficiary of the pandemic. The disclosure of the register of interests comes just days after a health expert branded the swine flu outbreak a 'false pandemic' driven by the drug companies which stood to profit. The Government is now trying to offload up to Ł1billion worth of unwanted swine flu vaccine. Last July, the Department of Health warned of up 65,000 deaths, with 350 a day at the pandemic's peak. But the death toll now stands at just 251. SAGE was created to give Ministers recommendations on how to control and treat the virus. Official documents show some members are linked to vaccine manufacturer Baxter and to Roche, which makes Tamiflu. GSK, Baxter and Roche stand to make up to Ł1.5billion between them from Government contracts related to swine flu.
Note: For lots more on the Swine Flu "false pandemic," click here.
Ministers are preparing to offload millions of unwanted swine flu vaccines, it has emerged, as officials predicted that there will be no third wave of the pandemic this winter. Millions of [dollars] could be wasted if the Government is unable to get out of orders for the vaccine it has placed with GlaxoSmithKline (GSK), the pharmaceutical giant. Officials confirmed that they are considering a number of options, including attempting to sell or give away millions of the vaccines. They also considering whether to stand down the National Pandemic Flu Service, the network of call centres which diagnose swine flu and hand out antiviral medications. In May, even before a pandemic had been declared, ministers had signed contracts thought to be worth around Ł100 million to deliver 90 million vaccines to Britain. Britain has now received almost 29 million doses of the H1N1 vaccine, but only just over 3.7 million have been given out and in total the Government has announced plans to inoculate only 14 million people.
Note: For a powerful insight into the corrupt symbiosis between pharmaceutical corporations and government, read this analysis by Marcia Angell, former editor of the New England Journal of Medicine. For lots more on the swine flu scare, click here.
A new report finds that the Centers for Disease Control and Prevention did a poor job of screening medical experts for financial conflicts when it hired them to advise the agency on vaccine safety. Most of the experts who served on advisory panels in 2007 to evaluate vaccines for flu and cervical cancer had potential conflicts that were never resolved, the report said. Some were legally barred from considering the issues but did so anyway. In the report ... Daniel R. Levinson, the inspector general of the Department of Health and Human Services, found that the centers failed nearly every time to ensure that the experts adequately filled out forms confirming they were not being paid by companies with an interest in their decisions. The report found that 64 percent of the advisers had potential conflicts of interest that were never identified or were left unresolved by the centers. Thirteen percent failed to have an appropriate conflicts form on file at the agency at all, which should have barred their participation in the meetings entirely, Mr. Levinson found. And 3 percent voted on matters that ethics officers had already barred them from considering.
Dr. Julie Gerberding, former director of the U.S. Centers for Disease Control and Prevention, was named president of Merck & Co Inc's vaccine division. Gerberding, who led the CDC from 2002 to 2009 and stepped down when President Barack Obama took office, will head up the company's $5 billion global vaccine business that includes shots to prevent chickenpox, cervical cancer and pneumonia. She had led CDC from one crisis to another, including the investigation into the anthrax attacks that killed five people in 2001, the H5N1 avian influenza, the global outbreak of severe acute respiratory syndrome, or SARS, and various outbreaks of food poisoning. She may be charged with reigniting flagging sales of Merck's Gardasil vaccine to prevent cervical cancer by protecting against human papillomavirus or HPV. After an encouraging launch Gardasil sales have been falling and were down 22 percent in the third quarter at $311 million.
Note: So the head of the CDC now is in charge of vaccines at one of the biggest pharmaceutical companies in the world. Could this be considered conflict of interest? Could this possibly be payback for supporting the vaccine agenda so strongly for years? For more on the risks and dangers of vaccines, click here.
American special forces have conducted multiple clandestine raids into Pakistan's tribal areas as part of a secret war in the border region where Washington is pressing to expand its drone assassination programme. A former Nato officer said the incursions, only one of which has been previously reported, occurred between 2003 and 2008, involved helicopter-borne elite soldiers stealing across the border at night, and were never declared to the Pakistani government. "The Pakistanis were kept entirely in the dark about it. It was one of those things we wouldn't confirm officially with them," said the source, who had detailed knowledge of the operations. Such operations are a matter of sensitivity in Pakistan. While public opinion has grudgingly tolerated CIA-led drone strikes in the tribal areas, any hint of American "boots on the ground" is greeted with virulent condemnation. After the only publicly acknowledged special forces raid in September 2008, Pakistan's foreign office condemned it as "a grave provocation" while the military threatened retaliatory action. The military source said that was the fourth raid of previous years. The secretive nature of the raids underscores the suspicious nature of the relationship between the two allies as they argue about Washington's latest demands.
Note: For lots more from reliable sources on the secret realities of the "war on terrorism," click here.
Deep inside an 86-page supplement to United States export regulations is a single sentence that bars U.S. exports of vaccines for avian bird flu and dozens of other viruses to five countries designated "state sponsors of terrorism." The reason: Fear that they will be used for biological warfare. Under this little-known policy, North Korea, Iran, Cuba, Syria and Sudan may not get the vaccines unless they apply for special export licenses, which would be given or refused according to the discretion and timing of the U.S. Three of those nations -- Iran, Cuba and Sudan -- also are subject to a ban on all human pandemic influenza vaccines as part of a general U.S. embargo. The regulations, which cover vaccines for everything from Dengue fever to the Ebola virus, have raised concern within the medical and scientific communities. Officials from the U.S. Department of Health and Human Services and the Centers for Disease Control and Prevention said they were not even aware of the policies until contacted by The Associated Press ... and privately expressed alarm. They make "no scientific sense," said Peter Palese, chairman of the microbiology department at Mount Sinai School of Medicine in New York. Some experts say the idea of using vaccines for bioweapons is far-fetched.
Drug company GlaxoSmithKline has told Canadian doctors to stop using one lot of its H1N1 vaccine until an investigation into a higher-than-expected number of severe allergic reactions is completed. The U.S. vaccine will not be identical to Arepanrix, the GSK H1N1 vaccine used in Canada. Arepanrix contains an adjuvant, a substance designed to boost the immune response, but adjuvants have never been approved for use in U.S. flu vaccines. Almost all of the 172,000 doses in question, distributed the week of Nov. 2 to six Canadian provinces, already have been administered, said Geoffrey Matthews, a spokeswoman for the Public Health Agency of Canada, which, with GSK and Health Canada, is investigating cases of anaphylaxis. Symptoms of anaphylaxis include trouble breathing, chest tightness and swelling of the mouth and throat. Six cases have been reported, Matthews says. In the USA, the Vaccine Adverse Event Reporting System said that as of Nov. 13 it had received 116 reports of serious health events related to the vaccine, including eight deaths – similar to the number in previous years after a similar number of seasonal flu vaccine doses had been shipped.
Note: For lots more on the risks of swine flu vaccines, click here.
Although federal health officials decline to use the word "peaked," the current wave of swine flu appears to have done so in the United States. Flu activity is coming down in all regions of the country, the Centers for Disease Control and Prevention said Friday, though it is still rising in Hawaii, Maine and some isolated areas. The World Health Organization said Friday that there were "early signs of a peak" in much of the United States. On Wednesday, the American College Health Association, which surveys over 250 colleges with more than three million students, said new cases of flu had dropped in the week ending Nov. 13. It was the first drop since school resumed in the fall, and it was significant – new cases were down 27 percent from the week before. And on Friday, Quest Diagnostics, the country's largest laboratory, said its tests of 142,000 suspected flu specimens since May showed that the flu peaked in late October. Nonetheless, Dr. Anne Schuchat, the director of immunization and respiratory diseases at the C.D.C., chose her words carefully, saying: "I wish I knew if we had hit the peak. Even if a peak has occurred, half the people who are going to get sick haven't gotten sick yet." The drop was clearly not caused by the swine flu vaccine drive, which has not gone as fast as the authorities had hoped.
Note: Just like the avian flu scare a few years ago, the swine flu hype has turned out to be largely a whimper, yet the pharmaceutical companies are happy, as again they have made billions of dollars from the massive amonts of vaccines and drugs purchased by the government with your tax dollars. For more, click here and here.
As Germany launched its mass-vaccination program against the H1N1 flu virus on Monday, the government found itself fending off accusations of favoritism because it was offering one vaccine believed to have fewer side effects to civil servants, politicians and soldiers, and another, potentially riskier vaccine to everyone else. The German government prepared for its mass-vaccination campaign earlier this year by ordering 50 million doses of the Pandemrix vaccine. The vaccine, manufactured by GlaxoSmithKline, contains an immunity-enhancing chemical compound, known as an adjuvant, whose side effects are not yet entirely known. The Interior Ministry confirmed that it had ordered a different vaccine, Celvapan, for government officials and the military. Celvapan, which is made by U.S. pharmaceutical giant Baxter, does not contain an adjuvant and is believed to have fewer side effects.
Swiss drugmaker Novartis said sales would grow faster than expected this year, even without a shot in the arm of up to $700 million from its H1N1 swine flu pandemic vaccine. Third-quarter net profit at Novartis ... nudged up 1 percent to $2.1 billion. This year is turning out to be better than initially feared for Novartis and other major pharmaceutical companies, thanks to hefty price increases and windfall sales arising from the H1N1 outbreak. Both Pfizer, the world's biggest drugmaker, and Eli Lilly topped earnings forecasts this week. Roche reported a sharp jump in sales of its Tamiflu drug for flu last week and analysts expect GlaxoSmithKline's Relenza will also see strong sales in the third quarter. On the vaccine front, Glaxo, Sanofi-Aventis and AstraZeneca are all expected to highlight an expected jump in fourth-quarter sales due to swine flu. The H1N1 flu vaccine is expected to contribute about $400-700 million of sales in the fourth quarter.
Note: Donald Rumsfeld personally made millions as a direct result of the avian flu scare a few year ago. For more on this, click here. For more on pharmaceutical corporation profiteering from swine flu vaccines, click here.
Jordan King was a typical baby. His parents called him vocal and vivacious. Then just before age 2, after a large battery of vaccinations, he simply withdrew from the world. "The real scary thing was when I noticed he wasn't looking at us any more in the eyes," Mylinda King, Jordan's mother, said. William Mead was a Pottery Barn baby model and met all the typical milestones. Then, also at age 2, after a set of vaccinations, William became very ill and he, too, changed forever. In both children, batteries of tests revealed dangerous levels of the brain toxin mercury in their systems. Their only known exposure: the mercury preservative once widely used in childhood shots. Dr. Bernadine Healy is the former head of the National Institutes of Health, and the most well-known medical voice yet to break with her colleagues on the vaccine-autism question. In an exclusive interview with CBS News, Healy said the question is still open. "I think that the public health officials have been too quick to dismiss the hypothesis as irrational," Healy said. Healy goes on to say public health officials have intentionally avoided researching whether subsets of children are “susceptible” to vaccine side effects - afraid the answer will scare the public. CBS News has learned the government has paid more than 1,300 brain injury claims in vaccine court since 1988, but is not studying those cases or tracking how many of them resulted in autism.”
Note: For a powerfully revealing article by Robert Kennedy, Jr. showing a major cover-up of this issue, click here. For another suppressed article on a published University of Pittsburgh study with strong evidence of an autism-vaccine link, click here.
Americans are still debating whether to roll up their sleeves for a swine flu shot, but companies have already figured it out: vaccines are good for business. Drug companies have sold $1.5 billion worth of swine flu shots, in addition to the $1 billion for seasonal flu they booked earlier this year. These inoculations are part of a much wider and rapidly growing $20 billion global vaccine market. "The vaccine market is booming," says Bruce Carlson, spokesperson at market research firm Kalorama, which publishes an annual survey of the vaccine industry. "It's an enormous growth area for pharmaceuticals at a time when other areas are not doing so well," he says. As always with pandemic flus, taxpayers are footing the $1.5 billion check for the 250 million swine flu vaccines that the government has ordered so far and will be distributing free to doctors, pharmacies and schools. In addition, Congress has set aside more than $10 billion this year to research flu viruses, monitor H1N1's progress and educate the public about prevention. Drugmakers pocket most of the revenues from flu sales. But some say it's not just drugmakers who stand to benefit. Doctors collect copayments for special office visits to inject shots, and there have been assertions that these doctors actually profit handsomely from these vaccinations. Pharmacies also charge co-payments or full price of about $25 to those without insurance.
Note: For a revealing article questioning the efficacy of vaccines, click here. And for a powerful CBS '60 Minutes' news clip clearly showing how the profit motive in vaccines endangers public health, click here.
As a group of healthcare workers, we are being mandated by a new New York state law to receive the seasonal flu vaccine and H1N1 vaccines. If we do not receive these vaccines by November 30th, that inaction is to be considered our resignation. We must sign a consent for the vaccines prior to their administration. The manufacturers have been granted immunity by the government; they cannot be sued for untoward effects. We do not want to receive these vaccines. Our educated studies of risks versus benefits conclude that the risks of the vaccine are greater than the possible benefits. All health care workers with direct patient care are mandated to receive the vaccine, so the coercion is real -- we cannot just go find a job "somewhere else." And the job market of 2009 does not offer opportunity in a different arena where we could still feed our families. We understand the fear that swine flu and influenza has generated. While our sources of information indicate that swine flu is not a pandemic, we know that the slanted research fed by the media offers results intended to frighten the public. We do not have the power to stop the fear that mass hype is able to generate. We hear the hype you are fed. We do not want to bring you harm, but we should not be forced into harm's way ourselves.
Note: For more on mandatory flu vaccinations, click here.
The existence of the influenza vaccine ... may give us a sense of false security when it comes to the possibility of a pandemic outbreak of influenza. In fact, the flu vaccine must be reformulated each year to keep pace with the newest variants of this fast-mutating virus. The recipe for making the flu vaccine is simple. Take the current year's variant of the influenza virus, throw it into a stew with a strain of virus that leads to rapid proliferation. Incorporate the fast-growing strain into its own genes and start replicating it. From there, it's an easy matter to take those plentiful viruses and attenuate them for a flu vaccine. But the scientists who must determine what virus will cause the next year's illness run a high chance of being wrong. Some observers have put the odds of success at no better than 50-50. Even when they are right, the vaccine lasts only as long as that year's strain. Experts thought they saw big-league trouble coming in February 1976, when a few cases of severe swine flu broke out among young military recruits in Fort Dix, N.J. One of them, Pvt. David Lewis, 19, died. Lewis and four others were shown to be infected with the same H1N1 influenza virus as was responsible for the 1918 pandemic. But the swine-flu pandemic never materialized. In retrospect, some critics now say 40 million Americans were vaccinated for nothing. In fact, the only real illness to result from the swine flu adventure was caused by the vaccine: about one thousand people developed Guillain-Barre syndrome, a serious paralytic disease that could be traced directly to an immunological response to the inoculation.
Note: This article also discusses how new, intensified farming techniques for chickens, pigs, and ducks are the prime breeding ground for viruses which spread around the world. A powerful CBS 60 Minutes clip on the 1976 swine flu scare is available here. The intrepid 60 Minutes team shows how greed and blatant corruption led to the death of hundreds and paralysis of thousands as a direct result of the vaccine developed that year, while only one person died from the flu. For lots more, click here.
In preparation for swine-flu vaccinations next month, Washington's Health Department ... temporarily suspended a rule that limits the amount of a mercury preservative [called Thimerosal] in vaccines given to pregnant women and children under the age of 3. Thimerosal has been eliminated from most vaccines in the United States, but it will be added to the bulk of the swine-flu vaccine. A vocal minority believes the compound could be linked to autism. About 15 percent of the vaccine supply will be mercury-free. Thimerosal will be added to the vaccine because it is being produced in vials that contain enough medication for 10 shots. The mercury compound kills bacteria, lowering the risk that the drug will be contaminated by needles used to withdraw separate doses. "Every time you introduce a needle, you run a risk of introducing a potential contaminant," said Dr. Tony Marfin, state epidemiologist for infectious disease. Mercury-free vaccine will be produced in single-dose vials. Nasal sprays do not contain mercury but are not recommended for children under the age of 2 and pregnant women, because they contain live, weakened virus. The law limiting the mercury preservative will be suspended for six months and applies only to the swine-flu vaccines. Once common in vaccines, thimerosal has been largely phased out in most wealthy nations. Children's vaccines in the United States are almost exclusively mercury-free, single-dose injections. After 1976's mass vaccination against a different swine-flu strain, about 500 people developed a neurological disorder called Guillain-Barre Syndrome (GBS), and some died. Scientists still haven't figured out why.
Note: To watch a vitally important 10-minute clip from CBS's 60 Minutes revealing government complicity in the deaths of 300 Americans and permanent paralysis of thousands more from the vaccine during the 1976 swine flu scare, click here. This is the most revealing clip by far on the swine flu that we've seen. For much more information on the dangers of thimerosal in vaccines, click here.
U.S. military troops will begin getting required swine flu shots in the next week to 10 days, with active duty forces deploying to war zones and other critical areas going to the front of the vaccine line. Air Force Gen. Gene Renuart also [said] that as many as 400 troops are ready to go to five regional headquarters around the country to assist federal health and emergency management officials. The Pentagon has bought 2.7 million vaccines, and 1.4 million of those will go to active duty military. National Guard troops on active duty are also required to receive the vaccine, as are civilian Defense Department employees who are in critical jobs. "Because I can compel people to get the shots, larger numbers will have the vaccine," said Renuart, commander of U.S. Northern Command. "They will, as a percentage of the population, be vaccinated more rapidly than many of us. So we may see some objective results, good or not, of the vaccinations." Shots will be doled out on a priority basis, with troops preparing to deploy first, followed by other active duty forces, particularly any who might be needed to quickly respond to a hurricane or other emergency. Inoculating the military is a key requirement of the Pentagon's emergency plan, as a way to ensure that troops are available to protect the nation. They also will be on tap to provide help to states if problems come up as the flu season continues.
Note: It is not made clear by this article precisely how military personnel will "assist" civilian authorities handle a mass swine flue vaccination program. The plans to use the military for this purpose are unprecedented and formerly illegal. For lots more from reliable sources on the dangers of vaccines, click here and here.
Health care workers are planning to take to the streets Tuesday at a rally in front of the Albany, N.Y. state capitol to protest mandatory vaccination. The rally is intended to call for "freedom of choice in vaccination and health care" and to protest mandatory vaccination for influenza and the H1N1 swine flu. "This vaccine has not been clinically tested to the same degree as the regular flu vaccine," Tara Accavallo, a registered nurse on Long Island, told Newsday. "If something happens to me, if I get seriously injured from this vaccine, who's going to help me?" While physicians, nurses, and medical technicians may not be known for their willingness to march on state capitols, a recent New York Department of Health requirement has sparked an unusually intense response. The August 13 regulations say that all health care workers who "could potentially expose patients" must be vaccinated for influenza by November 30 unless it would be "detrimental" to the recipient's health. This raises an obvious and important question: Under what circumstances can government officials order mandatory vaccination? And could the general public be ordered to roll up their sleeves for injections, even if there might be side effects beyond a sore arm or mild fever? The concern in New York also comes as skepticism of vaccination in general seems to be on the rise.
Note: For more on this protest, click here. Note that the U.S. government has granted immunity from lawsuits to the drug companies manufacturing the vaccines. So who will be responsible if there is a repeat of the 1976 swine flu vaccination campaign, where hundreds died and thousands were paralyzed by the vaccines?
A “perplexing” Canadian study linking H1N1 to seasonal flu shots is throwing national influenza plans into disarray and testing public faith in the government agencies responsible for protecting the nation's health. Distributed for peer review last week, the study confounded infectious-disease experts in suggesting that people vaccinated against seasonal flu are twice as likely to catch swine flu. The paper has since convinced several provincial health agencies to announce hasty suspensions of seasonal flu vaccinations, long-held fixtures of public-health planning. “It has confused things very badly,” said Dr. Ethan Rubinstein, head of adult infectious diseases at the University of Manitoba. “And it has certainly cost us credibility from the public because of conflicting recommendations. Until last week, there had always been much encouragement to get the seasonal flu vaccine.” On Sunday Quebec joined Alberta, Saskatchewan, Ontario and Nova Scotia in suspending seasonal flu shots for anyone under 65 years of age. Quebec's Health Ministry announced it would postpone vaccinations until January. B.C. is expected to announce a similar suspension during a press conference Monday morning. Other provinces, including Manitoba, are still pondering a response to the research. Dr. Rubinstein, who has read the study, said it appears sound. “There are a large number of authors, all of them excellent and credible researchers,” he said. “And the sample size is very large – 12 or 13 million people taken from the central reporting systems in three provinces. The research is solid.”
Note: For lots more from reliable sources on the dangers of vaccines, click here.
The nation's political crosscurrents appear to have created vaccine skeptics of many stripes. Many citizens are less inclined than ever to accept the warnings of the Department of Health and Human Services or the recommendations of its Centers for Disease Control and Prevention, says Sandra Quinn, a University of Pittsburgh public health professor who has just completed a national survey of attitudes about the flu vaccine. Vaccine refusers have long decried vaccine mandates and campaigns as an unwarranted intrusion of parents' and local school boards' rights. For a new generation of vaccine skeptics, there are new objects of distrust. For some, it flows from a suspicion of the multinational corporations that develop and manufacture vaccines. For others, it comes from a belief that media outlets have hyped the pandemic flu story to secure the attention of readers and the revenue of advertisers. And many simply doubt the competency and independence of government agencies, which they believe are too inept, overwhelmed or co-opted by corporate interests to secure the safety of the nation's drugs and food supply. Adding to the wariness toward the forthcoming H1N1 vaccine is the fact that the formulations used on patients in the United States might require the use of adjuvants -- special agents added to a vaccine mix that rev up the immune system and foster a stronger immune response. While adjuvants have been used in vaccines in Europe for many years, the FDA has never approved them for widespread use in the United States. Some vaccine critics in Great Britain have charged that one adjuvant used in European formulations -- squalene -- is associated with a wide range of vague but persistent symptoms.
Note: Adjuvants are being added to vaccines, yet the resulting combined formula is not being tested for safety; the individual components are tested separately. The process for the testing of vaccines is endangering our health. For lots more on the dangers of vaccines and squalene in particular, read respected Dr. Joseph Mercola's incisive article available here.
Pharmaceutical companies will be able to produce about 3 billion doses of swine flu vaccine a year ... the World Health Organization said. The U.N. agency had previously predicted that companies would be able to make up to 5 billion doses each year. The World Health Organization admits that not everyone may need vaccination. "Most people will do well without the vaccine," WHO vaccine chief Marie-Paule Kieny told reporters. She said most people infected with the pandemic strain of the H1N1 virus have a mild illness and recover by themselves. Addressing concerns about the safety of the pandemic vaccine, WHO said trials to date suggest it is as safe as a regular seasonal flu shot. Kieny said large-scale vaccination programs would probably detect some cases of severe reaction following the vaccination, but that those would likely have occurred anyway without vaccination. The agency is urging countries to monitor the vaccination procedure for possible further side effects. Meanwhile WHO Director-General Dr. Margaret Chan repeated Thursday her recommendation that governments keep up their guard against swine flu but refrain from closing borders or restricting trade.
Note: With the cost of a regular flu vaccine dose ranging from about $20 to $30, do you think the pharmaceutical companies have any vested interest in the public being vaccinated? Let's see, 3 billion X $20 = $60 billion. Hmm. For more on the danger of this vaccine and rampant fear mongering, click here and here.
Important Note: Explore our full index to revealing excerpts of key major media news stories on several dozen engaging topics. And don't miss amazing excerpts from 20 of the most revealing news articles ever published.